Literature DB >> 24269917

Genome-wide approaches reveal EGR1-controlled regulatory networks associated with neurodegeneration.

Radosveta Koldamova1, Jonathan Schug2, Martina Lefterova3, Andrea A Cronican4, Nicholas F Fitz4, Faith A Davenport4, Alexis Carter4, Emilie L Castranio4, Iliya Lefterov5.   

Abstract

Early growth response gene 1 (Egr1) is a member of the immediate early gene (IEG) family of transcription factors and plays a role in memory formation. To identify EGR1 target genes in brain of Alzheimer's disease (AD) model mice - APP23, we applied chromatin immunoprecipitation (ChIP) followed by high-throughput DNA sequencing (ChIP-seq). Functional annotation of genes associated with EGR1 binding revealed a set of related networks including synaptic vesicle transport, clathrin-mediated endocytosis (CME), intracellular membrane fusion and transmission of signals elicited by Ca(2+) influx. EGR1 binding is associated with significant enrichment of activating chromatin marks and appears enriched near genes that are up-regulated in the brains of APP23 mice. Among the putative EGR1 targets identified and validated in this study are genes related to synaptic plasticity and transport of proteins, such as Arc, Grin1, Syn2, Vamp2 and Stx6, and genes implicated in AD such as Picalm, Psen2 and App. We also demonstrate a potential regulatory link between EGR1 and its newly identified targets in vivo, since conditions that up-regulate Egr1 levels in brain, such as a spatial memory test, also lead to increased expression of the targets. On the other hand, protein levels of EGR1 and ARC, SYN2, STX6 and PICALM are significantly lower in the brain of adult APP mice than in age-matched wild type animals. The results of this study suggest that EGR1 regulates the expression of genes involved in CME, vesicular transport and synaptic transmission that may be critical for AD pathogenesis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Animal model; Brain; ChIP-seq; Egr1; Histone modifications

Mesh:

Substances:

Year:  2013        PMID: 24269917      PMCID: PMC3939039          DOI: 10.1016/j.nbd.2013.11.005

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  70 in total

Review 1.  Transcription factors as targets of anticancer drugs.

Authors:  M Gniazdowski; M Czyz
Journal:  Acta Biochim Pol       Date:  1999       Impact factor: 2.149

2.  Propagation of adipogenic signals through an epigenomic transition state.

Authors:  David J Steger; Gregory R Grant; Michael Schupp; Takuya Tomaru; Martina I Lefterova; Jonathan Schug; Elisabetta Manduchi; Christian J Stoeckert; Mitchell A Lazar
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

3.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

Review 4.  Insights from genomic profiling of transcription factors.

Authors:  Peggy J Farnham
Journal:  Nat Rev Genet       Date:  2009-08-11       Impact factor: 53.242

Review 5.  Applications of the Morris water maze in the study of learning and memory.

Authors:  R D'Hooge; P P De Deyn
Journal:  Brain Res Brain Res Rev       Date:  2001-08

6.  Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors.

Authors:  Sabine I Mayer; Oliver G Rössler; Takeshi Endo; Patrick Charnay; Gerald Thiel
Journal:  J Cell Sci       Date:  2009-08-25       Impact factor: 5.285

7.  Induction of memory-associated immediate early genes by nerve growth factor in rat primary cortical neurons and differentiated mouse Neuro2A cells.

Authors:  Chad A Dickey; Dirson D De Mesquita; Dave Morgan; Keith R Pennypacker
Journal:  Neurosci Lett       Date:  2004-08-05       Impact factor: 3.046

8.  Up-regulation of tyrosine hydroxylase gene transcription by tetradecanoylphorbol acetate is mediated by the transcription factors Ets-like protein-1 (Elk-1) and Egr-1.

Authors:  Luisa Stefano; Jude Al Sarraj; Oliver G Rössler; Charles Vinson; Gerald Thiel
Journal:  J Neurochem       Date:  2006-03-03       Impact factor: 5.372

9.  Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells.

Authors:  Paul Renbaum; Rachel Beeri; Efrat Gabai; Merav Amiel; Moran Gal; Markus U Ehrengruber; Ephrat Levy-Lahad
Journal:  Gene       Date:  2003-10-30       Impact factor: 3.688

Review 10.  Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease.

Authors:  Chris G Parsons; Wojciech Danysz; Andrzej Dekundy; Irena Pulte
Journal:  Neurotox Res       Date:  2013-05-09       Impact factor: 3.911

View more
  32 in total

1.  Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.

Authors:  Shubhabrata Mukherjee; Joshua C Russell; Daniel T Carr; Jeremy D Burgess; Mariet Allen; Daniel J Serie; Kevin L Boehme; John S K Kauwe; Adam C Naj; David W Fardo; Dennis W Dickson; Thomas J Montine; Nilufer Ertekin-Taner; Matt R Kaeberlein; Paul K Crane
Journal:  Alzheimers Dement       Date:  2017-02-24       Impact factor: 21.566

Review 2.  The neuronal activity-driven transcriptome.

Authors:  Eva Benito; Angel Barco
Journal:  Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.590

3.  A transcriptional signature of Alzheimer's disease is associated with a metastable subproteome at risk for aggregation.

Authors:  Prajwal Ciryam; Rishika Kundra; Rosie Freer; Richard I Morimoto; Christopher M Dobson; Michele Vendruscolo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

4.  Podocyte histone deacetylase activity regulates murine and human glomerular diseases.

Authors:  Kazunori Inoue; Geliang Gan; Maria Ciarleglio; Yan Zhang; Xuefei Tian; Christopher E Pedigo; Corey Cavanaugh; Janet Tate; Ying Wang; Elizabeth Cross; Marwin Groener; Nathan Chai; Zhen Wang; Amy Justice; Zhenhai Zhang; Chirag R Parikh; Francis P Wilson; Shuta Ishibe
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

5.  RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.

Authors:  Iliya Lefterov; Jonathan Schug; Anais Mounier; Kyong Nyon Nam; Nicholas F Fitz; Radosveta Koldamova
Journal:  Neurobiol Dis       Date:  2015-06-10       Impact factor: 5.996

6.  Epigenetic regulation of neuronal immediate early genes is associated with decline in their expression and memory consolidation in scopolamine-induced amnesic mice.

Authors:  Sweta Srivas; Mahendra K Thakur
Journal:  Mol Neurobiol       Date:  2016-08-23       Impact factor: 5.590

7.  Egr2 contributes to age-dependent vulnerability to sevoflurane-induced cognitive deficits in mice.

Authors:  Ye-Ru Chen; Shu-Xia Zhang; Man Fang; Piao Zhang; You-Fa Zhou; Xin Yu; Xiang-Nan Zhang; Gang Chen
Journal:  Acta Pharmacol Sin       Date:  2022-05-16       Impact factor: 6.150

8.  Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia.

Authors:  Yong Xu; Weihua Yue; Yin Yao Shugart; Sheng Li; Lei Cai; Qiang Li; Zaohuo Cheng; Guoqiang Wang; Zhenhe Zhou; Chunhui Jin; Jianmin Yuan; Lin Tian; Jun Wang; Kai Zhang; Kerang Zhang; Sha Liu; Yuqing Song; Fuquan Zhang
Journal:  Schizophr Bull       Date:  2015-11-24       Impact factor: 9.306

9.  Distinguishing Alzheimer's Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis.

Authors:  Jay S Hanas; James R S Hocker; Christian A Vannarath; Megan R Lerner; Scott G Blair; Stan A Lightfoot; Rushie J Hanas; James R Couch; Linda A Hershey
Journal:  Brain Sci       Date:  2021-04-30

10.  Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.

Authors:  Anais Mounier; Danko Georgiev; Kyong Nyon Nam; Nicholas F Fitz; Emilie L Castranio; Cody M Wolfe; Andrea A Cronican; Jonathan Schug; Iliya Lefterov; Radosveta Koldamova
Journal:  J Neurosci       Date:  2015-08-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.